HRMS using a Q-Exactive series mass spectrometer for regulated quantitative bioanalysis: how, when, and why to implement

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Ramanathan R, Jemal M, Ramagiri S et al. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS. J. Mass. Spectrom. 46(6), 595–601 (2011).
  Medline CASGoogle Scholar
• 2 Korfmacher W. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures. Bioanalysis 3(11), 1169–1171 (2011).
  CASGoogle Scholar
• 3 Bateman KP, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative-qualitative data acquisition using a benchtop orbitrap mass spectrometer. J. Am. Soc. Mass. Spectrom. 20(8), 1441–1450 (2009).
  Medline CASGoogle Scholar
• 4 Zhang H, Zhang D, Ray K, Zhu M. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J. Mass. Spectrom. 44(7), 999–1016 (2009).
  Medline CASGoogle Scholar
• 5 Hopfgartner G, Tonoli D, Varesio E. High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices. Anal. Bioanal. Chem. 402(8), 2587–2596 (2012).
  Medline CASGoogle Scholar
• 6 Meyer M, Maurer H. Current applications of high-resolution mass spectrometry in drug metabolism studies. Anal. Bioanal. Chem. 403(5), 1221–1231 (2012).
  Medline CASGoogle Scholar
• 7 Zhang J, Maloney J, Drexler D et al. Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays. Bioanalysis 4(5), 581–593 (2012).
  CASGoogle Scholar
• 8 Murphy K, Bennett P, Duczak N Jr. High-throughput quantitation of large molecules using multiplexed chromatography and high-resolution/accurate mass LC-MS. Bioanalysis 4(9), 1013–1024 (2012).
  CASGoogle Scholar
• 9 Fung E, Jemal M, Aubry A. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here? Bioanalysis 5(10), 1277–1284 (2013). • Excellent, thoughtful review of the state of HRMS in regulated bioanalysis in 2013.
  CASGoogle Scholar
• 10 Huang M, Lin Z, Weng N. Applications of high-resolution ms in bioanalysis. Bioanalysis 5(10), 1269–1276 (2013). • Excellent, thoughtful review of the state of HRMS in regulated bioanalysis in 2013.
  CASGoogle Scholar
• 11 Bruce SJ, Rochat B, Beguin A et al. Analysis and quantification of vitamin D metabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry – a method comparison and validation. Rapid Commun. Mass Spectrom. 27(1), 200–206 (2013).
  Medline CASGoogle Scholar
• 12 Dillen L, Cools W, Vereyken L et al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis 4(5), 565–579 (2012).
  CASGoogle Scholar
• 13 Ding J, Lund ET, Zulkoski J, Lindsay JP, Mckenzie DL. High-throughput bioanalysis of bile acids and their conjugates using UHPLCuhplc coupled to HRMS. Bioanalysis 5(20), 2481–2494 (2013).
  CASGoogle Scholar
• 14 Fung E, Xia YQ, Aubry A, Zeng J, Olah T, Jemal M. Full-scan high resolution accurate mass spectrometry (HRMS) in regulated bioanalysis: LC-HRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879(27), 2919–2927 (2011).
  Medline CASGoogle Scholar
• 15 Li Y, Hackman M, Wang C. Quantitation of polypeptides (glucagon and salmon calcitonin) in plasma samples by ‘high resolution’ on a triple quadrupole mass spectrometer. Bioanalysis 4(6), 685–691 (2012).
  CASGoogle Scholar
• 16 Mekhssian K, Mess J, Garofolo F. Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma. Bioanalysis 6(13), 1767–1779 (2014).
  CASGoogle Scholar
• 17 Mulvana DE, Sturm R, Bowen CL et al. Overcoming triple quadrupole selectivity challenges by use of high-resolution accurate mass spectrometry to enable sensitive quantitation of a small molecule therapeutic in rabbit plasma. Presented at: 21st International Reid Bioanalytical Forum. Guildford, UK, 7–10 September 2015.
  Google Scholar
• 18 Plumb RS, Fujimoto G, Mather J et al. Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS. Bioanalysis 4(5), 605–615 (2012).
  CASGoogle Scholar
• 19 Ramagiri S, Garofolo F. Large molecule bioanalysis using Q-TOF without predigestion and its data processing challenges. Bioanalysis 4(5), 529–540 (2012). •• Excellent discussion of a mass extractions window's effect on selectivity and sensitivity of a quantitative HRMS assay.
  CASGoogle Scholar
• 20 Rousu T, Tolonen A. Comparison of unit resolution SRM and TOF-MS at 12,000 mass resolution for quantitative bioanalysis of 11 steroids from human plasma. Bioanalysis 4(5), 555–563 (2012).
  CASGoogle Scholar
• 21 Sturm RM, Jones BR, Shan L, Buckholz JE, Biondolillo RF, Mulvana DE. PD biomarker measurement by LC/MS/MS – resolving sensitivity and throughput challenges using high resolution mass spectrometry. Presented at: 16th Annual Land O'Lakes Bioanalytical Conference. Madison, WI, USA, 13–16 July 2015.
  Google Scholar
• 22 Tonoli D, Varesio E, Hopfgartner G. Quantification of acetaminophen and two of its metabolites in human plasma by ultra-high performance liquid chromatography-low and high resolution tandem mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 904, 42–50 (2012).
  Medline CASGoogle Scholar
• 23 Voelker T, Wang H, Irish M et al. Method development and validation of six bile acids for regulated bioanalysis: improving selectivity and sensitivity. Bioanalysis 5(10), 1229–1248 (2013).
  CASGoogle Scholar
• 24 Wang H, Bennett P. Performance assessment of microflow LC combined with high-resolution MS in bioanalysis. Bioanalysis 5(10), 1249–1267 (2013).
  CASGoogle Scholar
• 25 Wei C, Grace JE Jr., Zvyaga TA, Drexler DM. Utility of high-resolution accurate MS to eliminate interferences in the bioanalysis of ribavirin and its phosphate metabolites. Bioanalysis 4(15), 1895–1905 (2012).
  CASGoogle Scholar
• 26 L Lawson G, Cocks E, Tanna S. Quantitative determination of atenolol in dried blood spot samples by LC-HRMS: a potential method for assessing medication adherence. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 897, 72–79 (2012).
  MedlineGoogle Scholar
• 27 Li Y, Henion J, Abbott R, Wang P. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies. Bioanalysis 3(22), 2501–2514 (2011).
  CASGoogle Scholar
• 28 Oliveira RV, Henion J, Wickremsinhe ER. Automated direct extraction and analysis of dried blood spots employing on-line SPE high-resolution accurate mass bioanalysis. Bioanalysis 6(15), 2027–2041 (2014).
  Google Scholar
• 29 Sturm R, Henion J, Abbott R, Wang P. Novel membrane devices and their potential utility in blood sample collection prior to analysis of dried plasma spots. Bioanalysis 7(16), 1987–2002 (2015).
  CASGoogle Scholar
• 30 FDA Guidance for Industry Computerized Systems Used in Clinical Investigations (2007). www.fda.gov/OHRMS/DOCKETS/98fr/04d-0440-gdl0002.pdf.
  Google Scholar
• 31 Thermo Scientific. Best practices in Q exactive maintenance and troubleshooting. Presented at: iOrbi 5. Ithaca, NY, USA, 6 December 2014.
  Google Scholar
• 32 Bowen CL, Kehler JR, Boram S, Abberley L, Szapacs M, Evans C. Modify on the fly: triple quad to high resolution in support of a dermal clinical study requiring an ultra low LLOQ. Bioanalysis 8(3), 205–214 (2016). •• Excellent example of how HRMS was utilized to further the development of a therapeutic drug when the SRM sensitivity suffered from selectivity issues.
  CASGoogle Scholar
• 33 Glauser G, Grund B, Gassner AL et al. Validation of the mass-extraction-window for quantitative methods using liquid chromatography high resolution mass spectrometry. Anal. Chem. 88(6), 3264–3271 (2016).
  Medline CASGoogle Scholar
• 34 Gallien S, Domon B. Quantitative proteomics using the high resolution accurate mass capabilities of the quadrupole-orbitrap mass spectrometer. Bioanalysis 6(16), 2159–2170 (2014).
  CASGoogle Scholar
• 35 Peterson A, Russell J, Bailey D, Westphall M, Coon J. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11(11), 1475–1488 (2012).
  Medline CASGoogle Scholar
• 36 Fu Y, Xia Y, Flarakos J et al. Differential mobility spectrometry coupled with multiple ion monitoring in regulated LC-MS/MS bioanalysis of a therapeutic cyclic peptide in human plasma. Anal. Chem. 88(7), 3655–3661 (2016).
  Medline CASGoogle Scholar
• 37 Ciccimaro E, Ranasinghe A, D'arienzo C et al. Strategy to improve the quantitative LC-MS analysis of molecular ions resistant to gas-phase collision induced dissociation: application to disulfide-rich cyclic peptides. Anal. Chem. 86(23), 11523–11527 (2014). • Describes application of Survivor-SIM to a peptide therapeutic.
  Medline CASGoogle Scholar
• 38 Evans C. When you need a sensitive and selective method, the answer could be HR-MS?! Presented at: 9th Workshop on Recent Issues in Bioanalysis. Miami, FL, USA, 13–17 April 2015.
  Google Scholar
• 39 Henion J, Brewer E, Rule G. Sample preparation for LC/MS/MS: analyzing biological and environmental samples. Anal. Chem. 70(19), A650–A656 (1998).
  Google Scholar
• 40 Jemal M. High-throughput quantitative bioanalysis by LC/MS/MS. Biomed. Chromatogr. 14(6), 422–429 (2000).
  Medline CASGoogle Scholar
• 41 Korfmacher W. Foundation review: principles and applications of LC-MS in new drug discovery. Drug Discov. Today 10(20), 1357–1367 (2005).
  Medline CASGoogle Scholar
• 42 Zhou S, Song Q, Tang Y, Naidong W. Critical review of development, validation, and transfer for high throughput bioanalytical LC-MS/MS methods. Curr. Pharm. Anal. 1(1), 3–14 (2005).
  Google Scholar
• 43 Xia YQ, Wu ST, Jemal M. LC-FAIMS-MS/MS for quantification of a peptide in plasma and evaluation of FAIMS global selectivity from plasma components. Anal. Chem. 80(18), 7137–7143 (2008).
  Medline CASGoogle Scholar
• 44 Zerr A, Heunier L, Wood S, Struwe P. Application of differential ion mobility mass spectrometry to peptide quantitation. Presented at: European Bioanalysis Forum. Barcelona, Spain, 14–16 November 2012.
  Google Scholar
• 45 Sidibe J, Varesio E, Hopfgartner G. Quantification of ghrelin and des-acyl ghrelin in human plasma by using cubic-selected reaction-monitoring LCMS. Bioanalysis 6(10), 1373–1383 (2014).
  CASGoogle Scholar
• 46 Campbell J, Ramagiri S. Recognizing the potential benefits and pitfalls of high-resolution MS. Bioanalysis 5(10), 1157–1160 (2013).
  CASGoogle Scholar
• 47 Dillen L, Cuyckens F. High-resolution MS: first choice for peptide quantification? Bioanalysis 5(10), 1145–1148 (2013).
  CASGoogle Scholar
• 48 Liu W, Ng J, Meluzzi D, Bandeira N et al. Interpretation of tandem mass spectra obtained from cyclic nonribosomal peptides. Anal. Chem. 81(11), 4200–4209 (2009).
  Medline CASGoogle Scholar
• 49 Kellie J, Kehler J, Szapacs M. Application of high-resolution MS for development of peptide and large-molecule drug candidates. Bioanalysis 8(3), 169–177 (2016). • Provides evidence that HRMS and QQQ platforms provide identical PK data from an in-life sample set.
  CASGoogle Scholar
• 50 Delatour T, Mottier P, Gremaud E. Limits of suspicion, recognition and confirmation as concepts that account for the confirmation transitions at the detection limit for quantification by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1169(1), 103–110 (2007).
  Medline CASGoogle Scholar
• 51 Zheng N, Zeng J, Manney A et al. Quantitation of a PEGylated protein in monkey serum by UHPLC-HRMS using a surrogate disulfide-containing peptide: a new approach to bioanalysis and in vivo stability evaluation of disulfide-rich protein therapeutics. Anal. Chim. Acta 916, 42–51 (2016).
  Medline CASGoogle Scholar